Uncover the latest and most impactful research in Genetic Diversity Management in Conservation Biology. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the ...

See the U.S. News rankings for Molecular Biology and Genetics among the top universities in United States. Compare the academic programs at the world's best universities.

Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, today announced additions to its Scientific Advisory Board (SAB). The SAB includes leaders ...

- Company has decoded the biology of rejuvenation across the entire human genome and identified several potential gene therapy targets for rejuvenation CAMBRIDGE, England--(BUSINESS WIRE)--clock.bio, ...

Variant Bio, a genomics-driven AI drug discovery company, today announced an expansion of its multi-year research collaboration and license agreement with Boehringer Ingelheim. Building on the ...

Chroma Medicine and Nvelop Therapeutics announced their merger and subsequent launch of nChroma Bio, redefining the future of genetic medicines. nChroma combines potent epigenetic editing with ...

Enduro Genetics, a synthetic biology startup, raised €12 million ($12.4 million) in Series A funding from Supernova Invest, NOON Ventures, and Sandwater. The funding will be used to expand Enduro’s ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new ‌drug candidates to send into human ...

A team of researchers has conducted the largest and most comprehensive genome-wide association study (GWAS) to date of schizophrenia in individuals of African ancestry. The work was led by scientists ...

In an extraordinary leap forward for comparative oncology, biomedical scientists have discovered striking genetic and ...

In February last year, I downgraded the stock of BridgeBio Pharma, Inc. (BBIO) from Buy to Hold in a note for Seeking Alpha. As it turned out, this was a bad call, because nearly 15 months on, shares ...